Stephen Fanning has left Johnson & Johnson, where he was president of the McNeil specialty products division, to become the new president and CEO of Ocular Sciences. OC's founder and interim CEO, John Fruth, will remain as chairman, concentrating on strategic planning. OC's sales grew by 43 percent to $61.4 ...
Buying a membership today will give you:
To continue reading this article register now.